(Tyr15)-ACTH (7-15) is a modified fragment of adrenocorticotropic hormone (ACTH), with a tyrosine substitution at position 15 to enhance receptor binding and stability. The peptide plays a role in regulating cortisol release and adrenal function. Researchers use this analog to study ACTH receptor interactions and its effects on the adrenal gland and stress response pathways.
CAT No: A03006
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More